JARISLOWSKY FRASER Ltd Boosts Stock Position in Haleon plc (NYSE:HLN)

JARISLOWSKY FRASER Ltd boosted its stake in Haleon plc (NYSE:HLN) by 8.8% during the fourth quarter, Holdings Channel.com reports. The fund owned 697,108 shares of the company’s stock after purchasing an additional 56,615 shares during the quarter. JARISLOWSKY FRASER Ltd’s holdings in Haleon were worth $6,650,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. FMR LLC lifted its holdings in Haleon by 3.7% during the fourth quarter. FMR LLC now owns 108,827,814 shares of the company’s stock valued at $1,038,217,000 after purchasing an additional 3,909,545 shares in the last quarter. Wellington Management Group LLP raised its position in shares of Haleon by 67.5% during the 4th quarter. Wellington Management Group LLP now owns 15,328,325 shares of the company’s stock worth $146,232,000 after purchasing an additional 6,175,835 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in Haleon by 0.8% in the 4th quarter. Envestnet Asset Management Inc. now owns 7,630,307 shares of the company’s stock valued at $72,793,000 after buying an additional 58,444 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Haleon by 18.3% in the 4th quarter. JPMorgan Chase & Co. now owns 6,014,903 shares of the company’s stock worth $57,382,000 after buying an additional 930,701 shares during the last quarter. Finally, Northern Trust Corp increased its stake in Haleon by 27.7% during the 4th quarter. Northern Trust Corp now owns 5,412,542 shares of the company’s stock worth $51,636,000 after buying an additional 1,172,931 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Morgan Stanley upgraded Haleon from an “equal weight” rating to an “overweight” rating and set a $11.25 target price on the stock in a research report on Friday. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Haleon in a report on Monday, March 3rd. Hsbc Global Res lowered shares of Haleon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. HSBC restated a “hold” rating on shares of Haleon in a research report on Wednesday, March 5th. Finally, Barclays reaffirmed an “overweight” rating on shares of Haleon in a research note on Tuesday. Five analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $11.25.

Haleon Trading Up 1.7 %

Shares of HLN opened at $10.75 on Friday. Haleon plc has a 12-month low of $8.24 and a 12-month high of $10.85. The firm has a market capitalization of $48.48 billion, a P/E ratio of 31.62, a P/E/G ratio of 2.82 and a beta of 0.24. The firm has a 50-day moving average price of $10.20 and a 200 day moving average price of $9.84. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44.

Haleon (NYSE:HLN) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The business had revenue of $3.54 billion during the quarter, compared to analysts’ expectations of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. Sell-side analysts forecast that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The firm also recently announced a — dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be given a $0.1166 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a yield of 1.6%. This is an increase from Haleon’s previous — dividend of $0.05. Haleon’s payout ratio is currently 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.